Risk of Needing Nursing Home Care Is Rising

This article originally appeared here.
Share this content:
Risk of Needing Nursing Home Care Is Rising
Risk of Needing Nursing Home Care Is Rising

TUESDAY, Aug. 29, 2017 (HealthDay News) -- More than half of Americans will require nursing home care at some point in their lives, according to a report published online Aug. 28 in the Proceedings of the National Academy of Sciences.

Michael Hurd, Ph.D., director of the RAND Center for the Study of Aging in Santa Monica, Calif., and colleagues analyzed 18 years of data from the Health and Retirement Study, which is a project sponsored by the U.S. National Institute on Aging and the U.S. Social Security Administration. The team estimated how many days individuals will spend in nursing homes and how much they will spend out-of-pocket.

The researchers found that 56 percent of individuals 57 to 61 years of age will stay at least one night in a nursing home at some point in their life, with 32 percent paying at least some of the cost out-of-pocket. Total out-of-pocket expenditures from age 57 were estimated at roughly $7,300, but the 95th percentile of spending approached $47,000. The team noted that a shift toward shorter nursing home stays may account for higher estimates of nursing home use. Nursing home stays of 21 nights or less rose from 28.1 percent in 1998 to 33.9 percent in 2010.

"We conclude that the percentage of people ever staying in nursing homes is substantially higher than previous estimates, at least partly due to an increase in nursing home episodes of short duration," the authors write. "Average lifetime out-of-pocket costs may be affordable, but some people will incur much higher costs."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »